[
  {
    "ts": null,
    "headline": "Analysts say Dexcom’s FDA warning unlikely to impact 2025 revenue",
    "summary": "Dexcom was issued with an FDA warning letter after issues with “manufacturing processes and quality management systems.”",
    "url": "https://finnhub.io/api/news?id=ebdb12d8634f3fae1d2487ad8db8092e38fbddb7e4943f704a422f05d5cddfa8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741716908,
      "headline": "Analysts say Dexcom’s FDA warning unlikely to impact 2025 revenue",
      "id": 133190165,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DXCM",
      "source": "Yahoo",
      "summary": "Dexcom was issued with an FDA warning letter after issues with “manufacturing processes and quality management systems.”",
      "url": "https://finnhub.io/api/news?id=ebdb12d8634f3fae1d2487ad8db8092e38fbddb7e4943f704a422f05d5cddfa8"
    }
  },
  {
    "ts": null,
    "headline": "Patient Monitoring Stocks Q4 Results: Benchmarking ResMed (NYSE:RMD)",
    "summary": "The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how ResMed (NYSE:RMD) and the rest of the patient monitoring stocks fared in Q4.",
    "url": "https://finnhub.io/api/news?id=edcd17591e16f5610e0dc66a40559718f5f5035a7577f1bbbb9e78a7eaae9b27",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741684059,
      "headline": "Patient Monitoring Stocks Q4 Results: Benchmarking ResMed (NYSE:RMD)",
      "id": 133189329,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DXCM",
      "source": "Yahoo",
      "summary": "The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how ResMed (NYSE:RMD) and the rest of the patient monitoring stocks fared in Q4.",
      "url": "https://finnhub.io/api/news?id=edcd17591e16f5610e0dc66a40559718f5f5035a7577f1bbbb9e78a7eaae9b27"
    }
  }
]